EquityFlow
›
Companies
› InProTher
InProTher
Biotech
· Copenhagen, DK
Immuno-oncology targeting Human Endogenous Retroviruses (HERVs)
Funding history
Date
Round
Amount
May 2023
Seed
Copenhagen biotech InProTher raised EUR6M seed for its HERV-targeting cancer immunotherapy.
$6.5M
Investors
European Innovation Council Fund
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →